206 related articles for article (PubMed ID: 26510907)
1. Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry.
Xiao WJ; Zhu Y; Dai B; Zhang HL; Shi GH; Shen YJ; Zhu YP; Ye DW
Oncotarget; 2015 Dec; 6(42):44955-62. PubMed ID: 26510907
[TBL] [Abstract][Full Text] [Related]
2. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
Tran TB; Liou D; Menon VG; Nissen NN
Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
[TBL] [Abstract][Full Text] [Related]
4. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
Kebebew E; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):872-8. PubMed ID: 16680602
[TBL] [Abstract][Full Text] [Related]
5. Beyond biology: the impact of marital status on survival of patients with adrenocortical carcinoma.
Klaassen Z; Reinstatler L; Terris MK; Underwood W; Moses KA
Int Braz J Urol; 2015; 41(6):1108-15. PubMed ID: 26742968
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Glenn JA; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Am J Surg; 2016 Jun; 211(6):1106-13. PubMed ID: 26810939
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
9. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
[TBL] [Abstract][Full Text] [Related]
10. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
11. Surgical management and clinical prognosis of adrenocortical carcinoma.
Dong D; Li H; Yan W; Ji Z; Mao Q
Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
[TBL] [Abstract][Full Text] [Related]
12. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study.
McAteer JP; Huaco JA; Gow KW
J Pediatr Surg; 2013 May; 48(5):1025-31. PubMed ID: 23701777
[TBL] [Abstract][Full Text] [Related]
14. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
[TBL] [Abstract][Full Text] [Related]
15. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T
Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884
[TBL] [Abstract][Full Text] [Related]
17. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
Livhits M; Li N; Yeh MW; Harari A
Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
[TBL] [Abstract][Full Text] [Related]
18. Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery.
Hermsen IG; Kerkhofs TM; den Butter G; Kievit J; van Eijck CH; Nieveen van Dijkum EJ; Haak HR;
Surgery; 2012 Jul; 152(1):50-6. PubMed ID: 22703895
[TBL] [Abstract][Full Text] [Related]
19. Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.
Nilubol N; Patel D; Kebebew E
World J Surg; 2016 Mar; 40(3):697-705. PubMed ID: 26510563
[TBL] [Abstract][Full Text] [Related]
20. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
